• Friday 08 September 2017

    Chairs: Joan Balcells and Nadia Depetris
    • 08:00
      O16.01 N-terminal-brain natriuretic peptide one week after severe burn injury

      J. Vuola, FI
    • 08:15
      O16.02 PCT: a good biomarker for sepsis in burn patients?

      L. Cabral, PT
    • 08:45
      O16.04 Infraclavicular plexus block for upper extremity burn debridement using a bromelain-based debriding enzyme (Nexobrid®)

      P. Gacto Sanchez, ES
    • 09:00
      O16.05 Is General Anesthesia Neccesary for Nexobrid Application? Our Experience

      I. Fakih, ES
  • Parallel session: PSYCHOSOCIAL 2

    Chair: Koen Maertens
    • 08:00
      O17.01 BrazilProfile, scenario and circumstances of burn trauma of patients in the reference hospital in Brasília capital of Brazil

      P. Saavedra, BR
    • 08:15
      O17.02 A comparative study of Self-inflicted burns

      S. Fidel Kinori, ES
    • 08:30
      O17.03 The social impact of burn injury: Associations between fear of negative evaluation, perceived stigmatization and self-esteem

      M. Egberts, NL
    • 08:45
      O17.04 The ”unseen scar” – A cross-sectional study of post major burn psychological impact and quality of life

      F. Mat Johar, MY
    • 09:00
      O17.05 Alcohol use and smoking in burn patients at the Helsinki Burn Center

      R. Palmu, FI
    • 09:15
      O17.06 Preventing Burns in children in Israel

      N. Michelson, IL
  • Parallel session: SURGERY ACUTE 3

    Chairs: Mireia Ruiz and Stan Monstrey
    • 08:00
      O18.01 An early experience of burn treatment with the NexoBrid

      A. Chrapusta, PL
    • 08:15
      O18.02 Cost analysis of enzymatic debridement of Burns in Spain

      J. Martínez-Méndez, ES
    • 08:30
      O18.03 Early experience in the use of NexoBrid™ in two Nordic Burn Centers

      O. Øglænd, NO
    • 08:45
      O18.04 5 Year Single Centre Review: The Management of Chemical Burns

      S. Martin, GB
    • 09:00
      O18.05 The use of NexoBrid in larger burns (over 15%) within or outside the label

      A. Boiangiu, RO
    • 09:15
      O18.06 Paediatric Friction Burns: 5-Year Experience from a UK Burns Unit

      C. O Boyle, GB
  • 08:00
    PAM SIM meeting Early activation ICU patients
  • Plenary session: Evidence Based Burn Care

    Chairs: Peter Vogt and Gerard Beerthuizen
    • 09:30
      PS 5.1 Evidence Based Burn Care

      S.E. Wolf, US
    • 09:50
      PS 5.2 Modulation of the hypermetabolic response: from drugs to exercise

      D.N. Herndon, US
    • 10:10
      PS 5.3 Patient’s assessment and reintegration into society: new paradigms?

      G. Fidel, ES
    • 10:30
      PS 5.4 Primary and secondary endpoints in burn resuscitation

      P. Guilabert, ES
  • 09:30
  • 11:00
    Coffee break

    Chairs: Tobias Tandrup and Mireille Pursad
    • 11:30
      O19.01 Rating scales for scar contracture: call for a functional approach

      M. Nieuwenhuis, NL
    • 11:45
      O19.02 Responsiveness of the POSAS for patients with burn scars following a physical therapy rehabilitation program

      J. Meirte, BE
    • 12:00
      O19.03 Effects of home exercise program on depression and quality of life in burn patients: pilot study

      M. Seyyah, TR
    • 12:15
      O19.04 The cultural adaptation and validation of patient and observer scar assessment scale into turkish

      M. Seyyah, TR
    • 12:30
      O19.05 The Intrarater and Interrater reliability of an automated hand measuring system vs manual measurements of the hand

      P. Moortgat, BE
    • 12:45
      O19.06 The effects of shockwave-therapy on burn scars, a randomised comparative trial

      J. Meirte, BE
  • Parallel session: WOUND HEALING 3

    Chair: Kees van der Vlies and Victor Andreu Sola
    • 11:30
      O20.01 Three donor site dressings in paediatric split-thickness skin grafting: a prospective randomised controlled trial

      C. McBride, AU
    • 11:45
      O20.02 Our experience in the treatment of chronic wounds of lower limbs

      N. Nor, UA
    • 12:00
      O20.03 Skin graft healing after autodermoplastic surgery for thermal burns

      V. Simonovs, LV
    • 12:15
      O20.04 Surface skin management in complex burn: an experience with Polihexanide-Bataine and Silver dressing in paste for wound bed preparation

      C. Segovia Donoso, CL
    • 12:30
      O20.05 Platelets Rich Plasma (PRP) gel post Fractional carbon dioxide LASER resurfacing for atrophic scars

      A. Youssef, ES
    • 12:45
      O20.06 Challenging the 21 day golden rule for wound closure: lessons learned from rapid enzymatic eschar removal in deep burns assessed by LDI

      H. Hoeksema, BE
  • Parallel session: OUTCOMES 4

    Chairs: Istvan Juhasz and Mireia Ruiz
    • 11:30
      O21.01 Magisterial Therapeutic Bacteriophage Preparations - Bacteriophages vs Superbugs

      G. Verbeken, BE
    • 11:45
      O21.03 Artificial dermis in burns and trauma one year of experience

      A. Andreone, ZA
    • 12:15
      O21.04 The Revised Baux Score Is Alive And Well

      B. Ter Horst, GB
    • 12:30
      O21.05 Patterns and predictors of change in POSAS patient scale scores for burn scars in the first 12 months post-burn

      Z. Rashaan, NL
    • 12:45
      O21.06 The use of NexoBrid rapid enzymatic debridement in the 2015 Romanian burn mass casualty incident: Ground breaking experience

      Y. Shoham, IL
  • 13:00
  • Lunch symposium Mallinckrodt "Emerging Opinion development for wound covering burns"

    Chair: Naiem Moiemen
    • 13:00
      Scientific Development History

      Lynn Allen-Hoffmann
    • 13:15
      Current clinical development

      James Holmes IV, USA
    • 13:30
      How could next generation anti-infective skin tissue look like?

      Angela Gibson, USA
    • 13:45
      Panel discussion
  • Plenary session: Presidents session: scar free healing

    Chair: Naiem Moiemen
    • 14:00
      PS 6.1 The biologic basis for prevention and treatment of hypertrophic scarring after burn injury

      E. Tredget, CA
    • 14:15
      PS 6.2 The clinical relevance of the Innate Immune response to burn injury: a Genomic understanding of the Innate Immune Tissue Response in burns

      R.G. Tompkins, US
    • 14:30
      PS 6.3 Scar free healing: the tissue engineering approach

      E. Middelkoop, NL
    • 14:45
      PS 6.4 Studying wound inflammation and scar free repair in model organisms from flies to man

      P. Martin, GB
    • 15:00
      PS 6.5 Challenges of research funding

      B. Eley, GB
  • Plenary PAM session: challenges of providing burn care in a multicultural society

    Chairs: Teresa Tredoux and Koen Maertens
    • 15:30
      PS 7.1 Ways to put Cultural Competence, Diversity and Inclusion into Practice

      R. Pfann, CH
    • 15:45
      PS 7.2 Stumbling blocks – what went wrong in one particular case?

      V. Cortes, CH
    • 16:00
      PS 7.3 Through the eyes of an Occupational Therapist: The pathway to recovery from a burn injury within a diverse South African context

      M. Pursad, ZA
    • 16:15
      PS 7.4 Overcoming nursing challenges and infection control problems in RCWMCH burn centre

      R. Goosen, ZA
    • 16:30
      PS 7.5 The cultural background and context of patients with a burn injury. How different worlds meet in a hospital

      S. Hammink, NL
    • 16:45
      PS7.6 Effective rehabilitation, lessons learned elsewhere

      R. Fanstone, GB
  • 17:00
    Coffee break

  • 17:30
    Poster Bullet Talks session
  • Parallel session: PREVENTION 1

    Chairs: Jacques Latarjet and Evan van Zoonen
    • 17:30
      O22.01 Burn epidemiology: feasability of a national data collection system for 100% patients needing hospitalization

      J. Latarjet, FR
    • 17:45
      O22.02 Non accidental burns - accidentally different?

      L Vieira, PT
    • 18:00
      O22.03 The state of the residential fire fatality problem in Sweden: epidemiology, risk factors, and event typologies

      F. Huss, SE
    • 18:15
      O22.04 A review of risk factors that are of influence on increased mortality in elderly burn patients after a house fire

      E. van Zoonen, NL
    • 18:30
      O22.05 Burn injury during long-term oxygen therapy in Denmark and Sweden: the potential role of smoking

      F. Huss, SE
    • 18:45
      O22.06 Impulsiveness and acute burn patients

      R. Palmu, FI
  • Parallel session: BASIC RESEARCH 3

    Chairs: Paul van Zuijlen and Dan Enescu
    • 17:30
      O23.01 Keratinocyte spray and fibrin – sequential or combined application?

      J. Valtonen, FI
    • 17:45
      O23.02 Accuracy of Laser Speckle Contrast Imaging in the assessment of pediatric scald wounds

      R. Mirdell, SE
    • 18:00
      O23.03 Inter-observer reliability of laser speckle contrast imaging for burn assessment

      R. Mirdell, SE
    • 18:15
      O23.04 The Use of Concentrated Surfactant Technology (CST) Based Wound Dressings In Biofilm Control and Prevention

      S. Percival, GB
    • 18:30
      O23.05 Biological activity and composition of burn wound exudate changes over time during the first week post burn

      P. Jafari, CH
    • 18:45
      O23.06 Long-lasting Glucagon-like Peptide 1 Analogue Exendin-4 Ameliorate the Secretion and Synthesis Function of Islets Isolated from Severely Scald Rats

      C. Shen, CN

    Chair: Renate Pfann
    • 17:30
      24.01 Treatment of the burned child

      L. Grossi Garriga, ES
    • 17:45
      O24.02 Evolution of Muscular Strength and Aerobic Capacity after Acute Pediatric Burns

      M. Akkerman, NL
    • 18:00
      O24.03 Quality of life and burn severity: a prospective study

      H. Hofland, NL
    • 18:15
      O24.04 Physical activity and participation: What is its significance in paediatric burns rehabilitation?

      S. Wicks, AU
    • 18:30
      O24.05 Virtual Reality (VR) - a chance for the rehabilitation of burned children

      J. Suss, DE
    • 18:45
      O24.06 Acceptability and feasibility of exercise therapy in an aquatic environment for patients after burn injury

      S. Sizoo, NL
  • 20:30
    Gala dinner